The fact that C-C motif chemokine ligand 5 (CCL5) modulates invasive and migratory behaviors of glioma through the phosphorylation of calmodulin-dependent protein kinase II (CaMKII) renders CCL5 and CaMKII interesting targets to halt glioma progression (55). This evidence concerns the gene CCL5 and central nervous system cancer.